• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不良妊娠结局在常规心血管风险预测中的作用。

The Role of Adverse Pregnancy Outcomes in Conventional Cardiovascular Risk Prediction.

机构信息

Division of Translational Health Sciences, RTI International, 307 Waverly Oaks Road, #1023, Waltham, MA, 02452, USA.

Health Care Financing and Payment, RTI International, 3040 E Cornwallis Road, Durham, NC, USA.

出版信息

Matern Child Health J. 2023 Oct;27(10):1774-1786. doi: 10.1007/s10995-023-03725-1. Epub 2023 Jun 6.

DOI:10.1007/s10995-023-03725-1
PMID:37280462
Abstract

OBJECTIVE

Approximately one-third of women in the U.S. experience an adverse pregnancy outcome (APO), which are recognized as sex-specific cardiovascular disease (CVD) risk factors. We examine if APOs confer additional CVD risk beyond that of traditional CVD risk factors.

METHODS

Women, age 40-79, with a pregnancy history and no pre-existing CVD were identified in the electronic health record of one health system (n = 2306). APOs included any APO, hypertensive disease of pregnancy (HDP), and gestational diabetes (GDM). Hazard ratios of time to CVD event were estimated from survival models using Cox proportional hazard regression. Discrimination, calibration, and net reclassification of re-estimated CVD risk prediction models including APOs were examined.

RESULTS

There was no significant association between any APO, HDP, or GDM and time to CVD outcome in survival models (95% confidence intervals all include 1). Including any APO, HDP, GDM in the CVD risk prediction model did not significantly improve discrimination and there were no clinically relevant changes in net reclassification of cases and non-cases. The strongest predictor of time to CVD event in the survival models was Black race, with hazard ratios ranging from 1.59 to 1.62, statistically significant for all three models.

CONCLUSION

Women with APOs did not have an additional risk of CVD, controlling for traditional risk factors in the PCE and this sex-specific factor did not improve risk prediction. Black race was consistently a strong predictor of CVD even with data limitations. Further study of APOs can help determine how to best use this information for CVD prevention in women.

摘要

目的

美国约有三分之一的女性经历不良妊娠结局(APO),这些结局被认为是特定于性别的心血管疾病(CVD)风险因素。我们研究 APO 是否会在传统 CVD 风险因素之外增加 CVD 风险。

方法

在一个健康系统的电子健康记录中,我们确定了年龄在 40-79 岁之间、有妊娠史且无预先存在的 CVD 的女性(n=2306)。APO 包括任何 APO、妊娠高血压疾病(HDP)和妊娠期糖尿病(GDM)。使用 Cox 比例风险回归从生存模型中估计 CVD 事件时间的风险比。检查了包括 APO 在内的 CVD 风险预测模型的再估计的区分度、校准和净重新分类。

结果

在生存模型中,任何 APO、HDP 或 GDM 与 CVD 结果之间均无显著关联(95%置信区间均包含 1)。在 CVD 风险预测模型中包含任何 APO、HDP、GDM 并不会显著提高区分度,并且病例和非病例的净重新分类没有临床相关变化。在生存模型中,CVD 事件时间的最强预测因素是黑人种族,其风险比范围为 1.59 至 1.62,所有三个模型均具有统计学意义。

结论

在控制 PCE 中的传统风险因素后,患有 APO 的女性没有增加 CVD 的风险,并且这种特定于性别的因素并不能改善风险预测。即使存在数据限制,黑人种族仍然是 CVD 的一个强有力的预测因素。对 APO 的进一步研究可以帮助确定如何最好地利用这些信息来预防女性的 CVD。

相似文献

1
The Role of Adverse Pregnancy Outcomes in Conventional Cardiovascular Risk Prediction.不良妊娠结局在常规心血管风险预测中的作用。
Matern Child Health J. 2023 Oct;27(10):1774-1786. doi: 10.1007/s10995-023-03725-1. Epub 2023 Jun 6.
2
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.孕期女性产前补充肌醇以预防妊娠期糖尿病。
Cochrane Database Syst Rev. 2015 Dec 17;2015(12):CD011507. doi: 10.1002/14651858.CD011507.pub2.
3
Different intensities of glycaemic control for women with gestational diabetes mellitus.妊娠期糖尿病女性不同强度的血糖控制
Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.基于不同风险特征和环境进行妊娠期糖尿病筛查以改善母婴健康。
Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4.
6
Preconception sleep, pregnancy loss, and adverse pregnancy outcomes among women with a history of pregnancy loss.有流产史女性的孕前睡眠、流产及不良妊娠结局
Hum Reprod. 2025 Jul 1;40(7):1366-1376. doi: 10.1093/humrep/deaf074.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
9
Use of biochemical tests of placental function for improving pregnancy outcome.利用胎盘功能生化检测改善妊娠结局。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD011202. doi: 10.1002/14651858.CD011202.pub2.
10
Different intensities of glycaemic control for women with gestational diabetes mellitus.不同强度的血糖控制对妊娠期糖尿病妇女的影响。
Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD011624. doi: 10.1002/14651858.CD011624.pub3.

本文引用的文献

1
Intravascular Ultrasound-Derived Calcium Score to Predict Stent Expansion in Severely Calcified Lesions.血管内超声衍生的钙评分预测严重钙化病变中的支架扩张。
Circ Cardiovasc Interv. 2021 Oct;14(10):e010296. doi: 10.1161/CIRCINTERVENTIONS.120.010296. Epub 2021 Oct 19.
2
Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women.不良妊娠结局与绝经后妇女动脉粥样硬化性心血管疾病风险的关联。
JAMA Cardiol. 2020 Dec 1;5(12):1390-1398. doi: 10.1001/jamacardio.2020.4097.
3
Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis.
高密度脂蛋白颗粒与血管域、性别和种族的缺血性事件之间的关联:一项汇总队列分析。
Circulation. 2020 Aug 18;142(7):657-669. doi: 10.1161/CIRCULATIONAHA.120.045713. Epub 2020 Jun 18.
4
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.载脂蛋白 B 颗粒与心血管疾病:一篇叙述性综述。
JAMA Cardiol. 2019 Dec 1;4(12):1287-1295. doi: 10.1001/jamacardio.2019.3780.
5
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
6
Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway.妊娠并发症史是否能改善心血管疾病风险预测?来自挪威亨于尔特研究的结果。
Eur Heart J. 2019 Apr 7;40(14):1113-1120. doi: 10.1093/eurheartj/ehy863.
7
Quantifying Importance of Major Risk Factors for Coronary Heart Disease.量化冠心病主要危险因素的重要性。
Circulation. 2019 Mar 26;139(13):1603-1611. doi: 10.1161/CIRCULATIONAHA.117.031855.
8
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention.长期获益法与标准风险评估法在初级预防中的应用:他汀类药物的适用性评估。
JAMA Cardiol. 2018 Nov 1;3(11):1090-1095. doi: 10.1001/jamacardio.2018.3476.
9
Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction.妊娠高血压疾病与 10 年心血管风险预测。
J Am Coll Cardiol. 2018 Sep 11;72(11):1252-1263. doi: 10.1016/j.jacc.2018.05.077.
10
The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women.妊娠并发症史对中年女性 10 年心血管疾病风险预测的价值。
Eur J Epidemiol. 2018 Oct;33(10):1003-1010. doi: 10.1007/s10654-018-0429-1. Epub 2018 Jul 30.